Literature DB >> 10873094

Immunohistochemical analyses of focal adhesion kinase expression in benign and malignant human breast and colon tissues: correlation with preinvasive and invasive phenotypes.

W G Cance1, J E Harris, M V Iacocca, E Roche, X Yang, J Chang, S Simkins, L Xu.   

Abstract

The focal adhesion kinase (FAK) is a protein tyrosine kinase linked to signaling events between cells and the extracellular matrix. Studies at the Western blot level have demonstrated up-regulation of FAK expression in invasive breast and colon cancers. To assess p125FAK expression at the cellular level, we developed monoclonal antibodies that specifically detected FAK in formalin-fixed, paraffin-embedded tissue sections and analyzed the levels of FAK expression in human breast and colon tissues. Monoclonal antibody 4.47 demonstrated FAK-specific focal adhesion staining by immunofluorescence assays on BT-474 breast cancer cells and detected a Mr 125,000 protein by both Western blotting and immunoprecipitation analyses. Using immunohistochemical techniques, the expression of p125FAK was analyzed in 36 normal and 43 preinvasive or invasive human breast and colon tissues from individual patients. FAK was weakly expressed in most benign breast epithelium but was up-regulated at moderate or strong levels in 14 of 18 invasive breast carcinomas. In seven samples of ductal carcinoma-in situ, FAK was overexpressed. Borderline-to-weak expression of FAK was detected in the normal colonic epithelium. In the invasive colon cancers, FAK was overexpressed at moderate or strong levels in 13 of 15 tumors. Furthermore, FAK expression was up-regulated in areas of dysplastic, premalignant colon epithelium. These results provide the first evidence at the cellular level that FAK expression is variably overexpressed in breast and colon cancer and suggest that up-regulation occurs at an early stage of tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10873094

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  155 in total

Review 1.  Integrin signaling and mammary cell function.

Authors:  Franziska Schatzmann; Rebecca Marlow; Charles H Streuli
Journal:  J Mammary Gland Biol Neoplasia       Date:  2003-10       Impact factor: 2.673

2.  Oral delivery of PND-1186 FAK inhibitor decreases tumor growth and spontaneous breast to lung metastasis in pre-clinical models.

Authors:  Colin Walsh; Isabelle Tanjoni; Sean Uryu; Alok Tomar; Ju-Ock Nam; Hong Luo; Angelica Phillips; Neela Patel; Cheni Kwok; Gerald McMahon; Dwayne G Stupack; David D Schlaepfer
Journal:  Cancer Biol Ther       Date:  2010-05-15       Impact factor: 4.742

Review 3.  Src/FAK-mediated regulation of E-cadherin as a mechanism for controlling collective cell movement: insights from in vivo imaging.

Authors:  Alan Serrels; Marta Canel; Valerie G Brunton; Margaret C Frame
Journal:  Cell Adh Migr       Date:  2011-07-01       Impact factor: 3.405

4.  Tumor Necrosis Factor-α (TNFα)-induced Ceramide Generation via Ceramide Synthases Regulates Loss of Focal Adhesion Kinase (FAK) and Programmed Cell Death.

Authors:  María José Hernández-Corbacho; Daniel Canals; Mohamad M Adada; Mengling Liu; Can E Senkal; Jae Kyo Yi; Cungui Mao; Chiara Luberto; Yusuf A Hannun; Lina M Obeid
Journal:  J Biol Chem       Date:  2015-08-28       Impact factor: 5.157

5.  Dieckol from Ecklonia cava suppresses the migration and invasion of HT1080 cells by inhibiting the focal adhesion kinase pathway downstream of Rac1-ROS signaling.

Authors:  Sun Joo Park; You Jin Jeon
Journal:  Mol Cells       Date:  2012-02       Impact factor: 5.034

6.  Cellular responses to substrate topography: role of myosin II and focal adhesion kinase.

Authors:  Margo T Frey; Irene Y Tsai; Thomas P Russell; Steven K Hanks; Yu-Li Wang
Journal:  Biophys J       Date:  2006-02-24       Impact factor: 4.033

Review 7.  Targeting Pyk2 for therapeutic intervention.

Authors:  Christopher A Lipinski; Joseph C Loftus
Journal:  Expert Opin Ther Targets       Date:  2010-01       Impact factor: 6.902

Review 8.  Progress in researches about focal adhesion kinase in gastrointestinal tract.

Authors:  Hui-Fang Hao; Yoshio Naomoto; Xiao-Hong Bao; Nobuyuki Watanabe; Kazufumi Sakurama; Kazuhiro Noma; Yasuko Tomono; Takuya Fukazawa; Yasuhiro Shirakawa; Tomoki Yamatsuji; Junji Matsuoka; Munenori Takaoka
Journal:  World J Gastroenterol       Date:  2009-12-21       Impact factor: 5.742

Review 9.  Bi-directional signaling: extracellular matrix and integrin regulation of breast tumor progression.

Authors:  Scott Gehler; Suzanne M Ponik; Kristin M Riching; Patricia J Keely
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2013       Impact factor: 1.807

10.  Mammary epithelial-specific ablation of the focal adhesion kinase suppresses mammary tumorigenesis by affecting mammary cancer stem/progenitor cells.

Authors:  Ming Luo; Huaping Fan; Tamas Nagy; Huijun Wei; Chenran Wang; Suling Liu; Max S Wicha; Jun-Lin Guan
Journal:  Cancer Res       Date:  2009-01-15       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.